Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis

K. E. Piper, M. S. Rouse, K. L. Ronningen, J. M. Steckelberg, W. R. Wilson, Robin Patel

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The activity of trovafloxacin was compared with those of vancomycin and penicillin in a model of Streptococcus sanguis species group (trovafloxacin MIC, 0.125 μg/ml) and Streptococcus mitis species group (trovafloxacin MIC, 0.125 μg/ml) experimental endocarditis. Rabbits with catheter-induced aortic valve vegetations were given no treatment, trovafloxacin at 15 mg/kg of body weight three times a day (t.i.d.), vancomycin at 15 mg/kg twice a day, or penicillin at 1.2 x 106 IU t.i.d. After 3 days of treatment, the animals were sacrificed; cardiac valve vegetations were aseptically removed and cultured quantitatively. Penicillin was as active as vancomycin as measured by in vivo clearance of bacteria. Trovafloxacin was less active (P < 0.05) than vancomycin or penicillin against S. sanguis species group infection but had similar efficacy against S. mitis species group infection. Quinolones, despite MICs in the susceptible range, may not be active for serious infections caused by some viridans group streptococci.

Original languageEnglish (US)
Pages (from-to)2554-2556
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume44
Issue number9
DOIs
StatePublished - 2000

Fingerprint

Viridans Streptococci
Endocarditis
Vancomycin
Penicillins
Streptococcus mitis
Streptococcus sanguis
Infection
Quinolones
Heart Valves
Aortic Valve
Catheters
Body Weight
trovafloxacin
Rabbits
Bacteria

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis. / Piper, K. E.; Rouse, M. S.; Ronningen, K. L.; Steckelberg, J. M.; Wilson, W. R.; Patel, Robin.

In: Antimicrobial Agents and Chemotherapy, Vol. 44, No. 9, 2000, p. 2554-2556.

Research output: Contribution to journalArticle

Piper, K. E. ; Rouse, M. S. ; Ronningen, K. L. ; Steckelberg, J. M. ; Wilson, W. R. ; Patel, Robin. / Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis. In: Antimicrobial Agents and Chemotherapy. 2000 ; Vol. 44, No. 9. pp. 2554-2556.
@article{d6f0a11b5d304344baa8a1062c199d60,
title = "Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis",
abstract = "The activity of trovafloxacin was compared with those of vancomycin and penicillin in a model of Streptococcus sanguis species group (trovafloxacin MIC, 0.125 μg/ml) and Streptococcus mitis species group (trovafloxacin MIC, 0.125 μg/ml) experimental endocarditis. Rabbits with catheter-induced aortic valve vegetations were given no treatment, trovafloxacin at 15 mg/kg of body weight three times a day (t.i.d.), vancomycin at 15 mg/kg twice a day, or penicillin at 1.2 x 106 IU t.i.d. After 3 days of treatment, the animals were sacrificed; cardiac valve vegetations were aseptically removed and cultured quantitatively. Penicillin was as active as vancomycin as measured by in vivo clearance of bacteria. Trovafloxacin was less active (P < 0.05) than vancomycin or penicillin against S. sanguis species group infection but had similar efficacy against S. mitis species group infection. Quinolones, despite MICs in the susceptible range, may not be active for serious infections caused by some viridans group streptococci.",
author = "Piper, {K. E.} and Rouse, {M. S.} and Ronningen, {K. L.} and Steckelberg, {J. M.} and Wilson, {W. R.} and Robin Patel",
year = "2000",
doi = "10.1128/AAC.44.9.2554-2556.2000",
language = "English (US)",
volume = "44",
pages = "2554--2556",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis

AU - Piper, K. E.

AU - Rouse, M. S.

AU - Ronningen, K. L.

AU - Steckelberg, J. M.

AU - Wilson, W. R.

AU - Patel, Robin

PY - 2000

Y1 - 2000

N2 - The activity of trovafloxacin was compared with those of vancomycin and penicillin in a model of Streptococcus sanguis species group (trovafloxacin MIC, 0.125 μg/ml) and Streptococcus mitis species group (trovafloxacin MIC, 0.125 μg/ml) experimental endocarditis. Rabbits with catheter-induced aortic valve vegetations were given no treatment, trovafloxacin at 15 mg/kg of body weight three times a day (t.i.d.), vancomycin at 15 mg/kg twice a day, or penicillin at 1.2 x 106 IU t.i.d. After 3 days of treatment, the animals were sacrificed; cardiac valve vegetations were aseptically removed and cultured quantitatively. Penicillin was as active as vancomycin as measured by in vivo clearance of bacteria. Trovafloxacin was less active (P < 0.05) than vancomycin or penicillin against S. sanguis species group infection but had similar efficacy against S. mitis species group infection. Quinolones, despite MICs in the susceptible range, may not be active for serious infections caused by some viridans group streptococci.

AB - The activity of trovafloxacin was compared with those of vancomycin and penicillin in a model of Streptococcus sanguis species group (trovafloxacin MIC, 0.125 μg/ml) and Streptococcus mitis species group (trovafloxacin MIC, 0.125 μg/ml) experimental endocarditis. Rabbits with catheter-induced aortic valve vegetations were given no treatment, trovafloxacin at 15 mg/kg of body weight three times a day (t.i.d.), vancomycin at 15 mg/kg twice a day, or penicillin at 1.2 x 106 IU t.i.d. After 3 days of treatment, the animals were sacrificed; cardiac valve vegetations were aseptically removed and cultured quantitatively. Penicillin was as active as vancomycin as measured by in vivo clearance of bacteria. Trovafloxacin was less active (P < 0.05) than vancomycin or penicillin against S. sanguis species group infection but had similar efficacy against S. mitis species group infection. Quinolones, despite MICs in the susceptible range, may not be active for serious infections caused by some viridans group streptococci.

UR - http://www.scopus.com/inward/record.url?scp=0033840172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033840172&partnerID=8YFLogxK

U2 - 10.1128/AAC.44.9.2554-2556.2000

DO - 10.1128/AAC.44.9.2554-2556.2000

M3 - Article

C2 - 10952616

AN - SCOPUS:0033840172

VL - 44

SP - 2554

EP - 2556

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 9

ER -